GMP IPO Watch
Innovision IPO Final Call: Will the Price Cut and Extension Save the Day?
The ₹306 crore Innovision Limited IPO officially closes today, March 17, 2026. After a slow start led to a revised price band of ₹494–₹519 and a 5-day extension, institutional investors have finally moved in. With the overall subscription crossing 1.2x and a recovering GMP, we look at the final numbers before the window shuts at 5:00 PM.
Live IPO tracking available
Check GMP movement, allotment details, subscription demand, and deeper IPO context for this company.
Use these shortcuts to keep exploring
The archive button opens all articles from this category. The IPO details button opens the live IPO page on your GMP site in a new tab.
1. The "Final Countdown" Status
The extension seems to have worked. While retail interest remains cautious, the overall issue is now comfortably subscribed as of this morning.
Overall Subscription: 1.20x to 1.25x (and climbing).
QIB (Institutions): 12.58x—Big players have heavily backed the revised price.
NII (HNIs): 2.63x—High-net-worth individuals have turned positive in the last 24 hours.
Retail Individual Investors: 0.28x—This segment remains the most hesitant, likely due to the "commoditized" nature of the manpower business.
2. Updated IPO Timeline (The New Schedule)
Because of the extension, the listing has been pushed back. Here is the calendar for allottees:
| Event | New Revised Date |
|---|---|
| IPO Close Date | Today, March 17, 2026 (5 PM) |
| Basis of Allotment | Wednesday, March 18, 2026 |
| Refunds/Demat Credit | Thursday, March 19, 2026 |
| Listing Date | Friday, March 20, 2026 (NSE & BSE) |
3. Grey Market Premium (GMP) Update
The sentiment is shifting. After spending days at ₹0, the GMP has recovered to approximately ₹19–₹26.
Estimated Listing Price: ~₹538 to ₹545.
Potential Gain: 3.6% to 5% over the upper price band of ₹519.
Note: While not a "blockbuster" gain, the movement into positive territory suggests the market is finding value at the new lower price.
4. Why the Market was Hesitant (and Why it Changed)
The "Too Expensive" Tag: The original P/E of 35x was seen as aggressive. At the revised price of ₹519, the valuation is more in line with industry peers.
The Growth Story: Despite the slow start, you can't ignore the numbers. Revenue jumped from ₹258 Cr in FY23 to ₹896 Cr in FY25.
Efficiency: A 35.45% Return on Net Worth (RoNW) is actually the highest in its peer group, which is likely why the QIB (Institutional) portion is now oversubscribed by 12 times.
5. Key Risks to Remember
The NHAI Factor: Their toll management business depends entirely on one client—the NHAI.
Thin Margins: As a manpower-intensive business, their EBITDA margin is roughly 5.78%. There isn't much "cushion" if labor costs or regulations change suddenly.
Working Capital: It’s a cash-hungry business. The IPO is raising ₹119 crore just to keep the daily operations running smoothly.
6. Final Verdict: To Apply or Skip?
For Listing Gain Seekers: The low GMP (under 5%) suggests this is not the right choice for a "quick flip."
For Long-Term Investors: If you believe Innovision can leverage its 14,000+ workforce and massive revenue growth to improve margins through its "Skill Development" wing, the revised price offers a decent entry point into a high-ROE business.
